Global Associate Medical Director, Rare Disease ( SMA/ALS) Evidence Generation and Education

Biogen•Cambridge, MA

11d•$183,000 - $252,000

About The Position

The Global Associate Medical Director, Evidence Generation and Education is a key member of the Global Medical Rare Disease team, reporting into the Rare Disease Global Medical Lead and supporting the Global Medical Directors, Rare Disease – ALS and SMA. This role helps execute the global evidence generation strategy across Biogen’s SMA and ALS portfolio, including registry-based studies, real-world data initiatives, biomarker and outcomes work, scientific communication, and cross-functional evidence planning. In addition, the role supports the education needs of Global Medical SMA and ALS teams by translating clinical, real-world, registry, and emerging scientific data into clear, compliant, and actionable training resources, scientific narratives, and medical education materials for internal and external stakeholders.

Requirements

Advanced degree (MD, PhD, PharmD, or equivalent) in a relevant scientific or clinical discipline.
Minimum 3–5 years of pharmaceutical industry experience, preferably in Medical Affairs, with exposure to rare disease therapeutic areas; experience with SMA, ALS, or related neuromuscular conditions preferred.
Experience supporting evidence generation activities, including clinical studies, real-world evidence, registry-based research, observational studies, natural history studies, or post-marketing surveillance programs.
Experience developing or supporting global medical education content, training curricula, scientific narratives, congress materials, or scientific communication resources for medical or field teams.
Strong scientific communication skills, including experience contributing to publications and congress presentations.
Ability to work collaboratively in a matrixed, cross-functional environment.
Working knowledge of global medical affairs compliance, Good Clinical Practice, data quality, and registry governance requirements.

Nice To Haves

Broad experience across Medical Affairs functions in Rare Disease, such as evidence generation, publications, medical communications, field medical support, medical information, or global medical education.
Clinical experience or subject matter familiarity with rare disease therapeutic areas, particularly SMA, ALS, or related neuromuscular conditions.
Experience with technical writing and development of medical education or field training materials.
Familiarity with real-world evidence, registries, natural history networks, biomarkers, health outcomes research, patient-reported outcomes, or comparative effectiveness methods as applied within Medical Affairs.
Strong organizational and project management skills, with the ability to coordinate multiple evidence generation and global education deliverables under the direction of a Medical Director.
Comfortable working within a global matrixed team environment, supporting cross-functional colleagues, regional medical teams, and external stakeholders to deliver evidence and education priorities.

Responsibilities

Supports the Medical Director, Rare Disease Evidence Generation – ALS and SMA in executing the global evidence generation strategy across Rare Disease portfolio including registries, real-world data, biomarker analyses, long-term outcomes, and other evidence sources.
Contribute to the design, prioritization, and execution of evidence generation initiatives, including registry-based studies, natural history collaborations, real-world data analyses, protocol development, statistical analysis plans, study reports, and data interpretation.
Develops, maintains, and delivers global medical education content and training materials that translate SMA and ALS evidence generation findings into clear, scientifically accurate resources for Global Medical, regional medical, field medical, and cross-functional partners.
Collaborates with Clinical Development, Biostatistics, Epidemiology, Health Economics and Outcomes Research, Value and Access, Regulatory, Patient Advocacy, Regional Medical, Commercial, publications, medical communications, and field medical partners to ensure evidence generation and education activities are strategically aligned and globally actionable.
Contributes & assists with drafting, reviewing, and coordinating manuscripts, abstracts, posters, congress presentations, advisory board materials, scientific narratives, and internal training resources related to SMA and ALS evidence generation.
Supports the development of global medical education curricula and continuing education resources for SMA and ALS, including disease state, product, registry, real-world evidence, biomarker, outcomes, patient identification, treatment optimization, and lifecycle strategy topics.
Partners with the Medical Director Rare Disease Evidence Generation lead and TA Global medical leads to synthesize global medical insights, registry data, external evidence, competitive intelligence, and regional feedback to identify evidence gaps, refine priorities, and address education needs across Global Medical SMA and ALS.
Supports relationships with external stakeholders, including registry steering committees, global medical experts, healthcare institutions, academic collaborators, registry partners, and advocacy organizations across the SMA and ALS landscape.
Supports internal governance forums, advisory boards, congresses, scientific meetings, and external expert engagements by preparing materials, coordinating inputs, capturing insights, and helping translate output into evidence and education actions.
Assists with operating rhythms for evidence review, prioritization, decision-making, budget tracking, project management, and delivery against measurable evidence-generation and education milestones.
Ensures all evidence generation, scientific communication, and medical education activities are conducted in accordance with Biogen’s compliance standards, Good Clinical Practice, relevant regulations, and applicable internal policies.

Benefits

Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation